Medicine

Related articles, background features and opinions about this topic.

End of Life Care: 'We're Reluctant to Talk About Death'

End of Life Care: 'We're Reluctant to Talk About Death'

SPIEGEL ONLINE - October 08, 2015

Interview Bestselling author Dr. Atul Gawande's new book focuses on medical care for the dying. In an interview, he speaks with SPIEGEL about end-of-life priorities, when treatment is a mistake and how rules in care homes are made to be broken. Interview Conducted by Laura Höflinger more... Comment ]

Whistleblower on Medical Research Fraud: 'Positive Results Are Better for Your Career'

Whistleblower on Medical Research Fraud: 'Positive Results Are Better for Your Career'

SPIEGEL ONLINE - September 10, 2015

In an interview, whistleblower Peter Wilmshurst discusses how pressure from Big Pharma corrupts research into new medicines and leads companies to cover up fraudulent data. He says he has no regrets about taking on an entire industry. By Rafaela von Bredow and Veronika Hackenbroch more... Comment ]


Conflict 7: Europe Isn't The Center of Focus

Conflict 7: Europe Isn't The Center of Focus

SPIEGEL ONLINE - April 01, 2015

An aim of IMI was to make the European pharmaceutical industry more competitive. But as the Combacte project shows, the real beneficiaries were often meant to be elsewhere. more...

Conflict 6: IMI Rules Come With Hitches

Conflict 6: IMI Rules Come With Hitches

SPIEGEL ONLINE - April 01, 2015

IMI is hoping to bring together representatives of industry, small- and medium-sized businesses and academics -- but in doing so, it is alienating many universities in Europe. Mid-sized research institutes are also having a tough time. more...


Conflict 5: Patients Are Becoming Lobbyists for the Industry

Conflict 5: Patients Are Becoming Lobbyists for the Industry

SPIEGEL ONLINE - April 01, 2015

Few IMI projects are more controversial: Patient representatives are schooled in EUPATI in order to better understand the development of medicines. But critics fear this could lead to prohibited influence. more...

Conflict 4: IMI Research Diverges from WHO Goals

Conflict 4: IMI Research Diverges from WHO Goals

SPIEGEL ONLINE - April 01, 2015

IMI's research projects are intended to create the medicines that are most essential to mankind. But instead of following WHO's priorities, IMI often pursues the pharmaceutical industry's agenda. more...


The Last Days of Annie Bus: A Chronicle of Dutch Euthanasia

The Last Days of Annie Bus: A Chronicle of Dutch Euthanasia

SPIEGEL ONLINE - February 04, 2015

Annie Bus of the Netherlands suffered from horrendous pain and paralysis, but not from a terminal illness. She wanted to die anyway. The story of how she got her wish demonstrates how difficult it is to set boundaries in a country that permits assisted suicide. By Laura Höflinger more... Comment ]

Students of Death: Euthanasia Doctors Seek Existential Answers at Auschwitz

Students of Death: Euthanasia Doctors Seek Existential Answers at Auschwitz

SPIEGEL ONLINE - November 21, 2014

A group of Belgium's leading practitioners of euthanasia recently visited the Auschwitz concentration camp memorial to learn more about death and humanity. The trip proved to be just as controversial for the doctors as it did insightful. By Katrin Kuntz more... Comment ]


Dubious Middlemen and Greedy Doctors: Inside Germany's Medical Tourism Business

Dubious Middlemen and Greedy Doctors: Inside Germany's Medical Tourism Business

SPIEGEL ONLINE - November 20, 2013

German hospitals are earning a billion euros a year with foreign patients. Sarkis Sargsyan is one, and like so many others, the Russian cancer patient fell into the clutches of a questionable middleman and greedy doctors. By Udo Ludwig, Matthias Schepp and Antje Windmann more... Comment ]

Sales Over Safety: Medical Device Makers Battle Tougher EU Laws

Sales Over Safety: Medical Device Makers Battle Tougher EU Laws

SPIEGEL ONLINE - October 17, 2013

The European Parliament is set to vote next week on stricter laws for licensing medical devices. Fearing a drop in sales, manufacturers have launched a major PR and lobbying campaign that exaggerates potential risks to patients. By Nicola Kuhrt more... Comment ]